Archaeal Power-to-biomethan producer Electrochaea GmbH has sold a BioCat bioreactor to the Danish CCU ...
Up To Date
Latest News
Oss-based oncology company Flindr Therapeutics BV has secured €20m to advance it first-in-class RNF31...
Finnish Nordic Bioproducts Group has opened a production facility to produce advanced cellulosic materials wit...
The Swiss biotech sector proved robust growth in 2023. Revenues in 2023 increased by CHF500m to CHF7.3bn....
Ipsen SA and RNA splicing modifier specialist Skyhawk Therapeutics Inc have entered a US$1.8bn licencing...
French drug maker Seabelife SAS will use a €1.5m price money to develop a new dual-acting necroptosis blocker...